$8 billion Acquisition of Iridium Communications, Rocket Lab to Build "Space Ecosystem" Challenging SpaceX
BlockBeats News, June 30, Rocket Lab announced on Monday that it will acquire satellite communications service provider Iridium Communications (IRDM.O) for approximately $8 billion, with the transaction expected to be completed by mid-2027. Iridium Communications shareholders will receive $27 per share in cash and company stock, with a total value of $54 per share, representing a 24.1% premium over the previous trading day.
This acquisition will integrate Rocket Lab's launch and satellite manufacturing business with Iridium Communications' global L-band satellite network, licensed spectrum resources, and over 2.5 million government, defense, aviation, maritime, and commercial customers, allowing it to form a vertically integrated model similar to SpaceX and Starlink.
This is Rocket Lab's fourth acquisition this year, and analysts believe that the transaction will immediately provide the company with a mature customer base and distribution network, whose value may exceed that of the hardware and spectrum resources themselves. To finance the cash portion, the company has secured $3.6 billion in bridge loan commitments from Deutsche Bank and JPMorgan.
It is worth noting that this deal comes as SpaceX completed an $86 billion IPO earlier this month, further expanding its satellite communications and AI infrastructure business, with SpaceX also having previously reached an agreement to acquire EchoStar's spectrum resources. Amidst the wave of consolidation in the aerospace industry, Rocket Lab is attempting to challenge SpaceX's leading position in the satellite communications field with a closed-loop "launch + satellite network" layout.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

The White House did not intervene in the decision-making of Nvidia's board of directors.
